Alembic Limited is an India-based company engaged in the business of development, manufacturing, and marketing of pharmaceutical products. The Company's segments include the Active Pharmaceutical Ingredients Business and the Real Estate Business. The Active Pharmaceutical Ingredients Business is engaged in the manufacturing and marketing of fermentation and chemistry-based active pharmaceutical ingredients (API). The Real Estate Business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. The Company provides certain commercial properties on a lease basis to various tenants. The Company is also engaged in research and development activities in Vadodara. It is also engaged in power generation through co-generation.

Employees

261

Sector

Real Estate Development & Operations

More about the company

Quotes

Date	Price	Change	Volume
26/08/26	₹98.66	+4.21%	112,371
25/08/26	₹94.67	+3.34%	168,716
24/08/26	₹91.61	-1.21%	28,613
21/08/26	₹92.73	+1.42%	56,656
20/08/26	₹91.43	+3.05%	75,598

Delayed Quote Bombay S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Bombay S.E. 11:02:19 26/08/2026 BST			5-day change	1st Jan Change
98.66 ^INR	+4.21%		+11.20%	-2.37%

08-11	Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-19	Alembic Limited Recommends Dividend for the Year Ended March 31, 2026	CI

Market Cap	25.33B 266M 228M 214M 195M 369M 371M 2.53B 981M 12.78B 997M 976M 42.33B	P/E 2025	8.14x	P/E 2026	5.74x
Enterprise Value	24.46B 256M 220M 207M 189M 356M 358M 2.44B 948M 12.34B 963M 942M 40.87B	EV / Sales 2025	11.2x	EV / Sales 2026	7.22x
Free-Float	27.58%	Yield 2025	2.44%	Yield 2026	3.38%

08-11	Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-19	Alembic Limited Recommends Dividend for the Year Ended March 31, 2026	CI
05-19	Alembic Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-23	Alembic Pharmaceuticals Incorporates Philippines Subsidiary	MT
02-12	Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
11-27	Bajaj Healthcare Limited Appoints Shreekumar Shankarnarayan Nair as Chief Operating Officer, Effective November 27, 2025	CI
11-17	Accenture Invests in AI Marketing Intelligence Platform Alembic	MT
11-17	Alert wrongly tagged to India's Alembic withdrawn	RE
11-17	Alembic raises $145 million to accelerate enterprise adoption of causal AI	RE
11-17	Accenture invests in Alembic to reinvent marketing measurement with data and Causal AI	RE
11-10	Alembic Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
12/08/25	Alembic Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
12/08/25	Alembic Limited Announces Resignation of Malika Amin as CEO, Effective 1 January, 2026	CI

04/07/25	Alembic : Annual Report 2024-25	PU
27/05/25	Supreme Court Rules Against Ex-Post Facto Environment Clearance	AQ
14/08/24	Alembic Pharmaceuticals announces USFDA Dabigatran Etexilate Capsules, 110 mg	AQ
25/07/24	Alembic Pharmaceuticals announces USFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg	AQ
07/08/23	Alembic Pharmaceuticals - Revenue up 18% to Rs. 1486 crores in Q-1 FY24	AQ

Alembic Limited Share Price

Stocks

ALEMBICLTD

INE426A01027

Real Estate Development & Operations

Valuation: Alembic Limited

Chart: Alembic Limited

Latest news : Alembic Limited

Press Releases: Alembic Limited

Quotes and Performance

Price Extremes

Managers and Directors: Alembic Limited

Other Real Estate Development & Operations

Financials

Company Profile

Quotes

1 day	+4.21%
1 week	+11.20%
Current month	+8.16%
1 month	+9.68%
3 months	+12.10%
6 months	+8.19%
Current year	-2.37%

1 week	87.25	99.47
1 month	82.75	99.47
Current year	70.64	104.25
1 year	70.64	108.55
3 years	70.64	169
5 years	55.52	169
10 years	25	169

Manager	Title	Age	Since
Udit Chirayu Amin CEO	Chief Executive Officer	46	30/09/2025
Rasesh J. Shah DFI	Director of Finance/CFO	-	12/08/2014
Kevalkumar B. Thakkar CMP	Compliance Officer	-	31/08/2023

Director	Title	Age	Since
Chirayu Ramanbhai Amin CHM	Chairman	78	20/08/1967
Malika Chirayu Amin BRD	Director/Board Member	71	01/07/1988
Udit Chirayu Amin BRD	Director/Board Member	46	23/04/2013

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALEMBIC LIMITED	+4.21%	+11.20%	-4.86%	+24.45%	255M
SUN HUNG KAI PROPERTIES LIMITED	-0.32%	+6.22%	+32.91%	+40.55%	46.21B
CHINA RESOURCES LAND LIMITED	+1.46%	+1.58%	+9.51%	+9.20%	31.19B
MITSUBISHI ESTATE CO., LTD.	+1.97%	+4.68%	+20.52%	+108.95%	28.02B
EMAAR PROPERTIES	+0.73%	-0.18%	-24.66%	+59.42%	26.28B
MITSUI FUDOSAN CO., LTD.	+0.43%	+5.04%	-4.28%	+45.69%	25.57B
CK ASSET HOLDINGS LIMITED	-0.26%	+2.36%	+25.15%	+9.81%	20.94B
ALPHA DHABI HOLDING	+1.45%	+1.32%	-33.51%	-61.15%	20.65B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	-0.12%	+3.79%	+10.63%	+85.58%	19.73B
CHINA OVERSEAS LAND & INVESTMENT LIMITED	+4.06%	+3.31%	-0.62%	-8.37%	19.25B
Average	+1.36%	+2.60%	+3.08%	+31.41%	23.81B
Weighted average by Cap.	+0.91%	+2.70%	+7.00%	+35.36%

	2025	2026
Net sales	2.22B 23.26M 19.97M 18.74M 17.12M 32.3M 32.46M 222M 85.95M 1.12B 87.35M 85.45M 3.71B	2.4B 25.16M 21.6M 20.27M 18.51M 34.94M 35.11M 240M 92.97M 1.21B 94.48M 92.42M 4.01B
Net income	3.11B 32.57M 27.96M 26.24M 23.97M 45.23M 45.45M 311M 120M 1.57B 122M 120M 5.19B	3.17B 33.28M 28.56M 26.81M 24.48M 46.21M 46.43M 317M 123M 1.6B 125M 122M 5.3B
Net Debt	-438M -4.59M -3.94M -3.7M -3.38M -6.38M -6.41M -43.8M -16.98M -221M -17.25M -16.88M -732M	-874M -9.16M -7.87M -7.38M -6.74M -12.72M -12.79M -87.36M -33.86M -441M -34.41M -33.66M -1.46B